FMR1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of FMR1 monoclonal antibodies for various research applications. FMR1 monoclonal antibodies enable precise detection in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FMR1, or Fragile X Mental Retardation 1, plays a crucial role in neuronal development and synaptic function. FMR1 regulates mRNA translation and influences cognitive processes, making it a significant focus in studies related to neurodevelopmental disorders, particularly Fragile X syndrome. Understanding FMR1 is vital for advancing research in genetics and neurobiology. FMR1 monoclonal antibodies support detailed investigations of molecular pathways and cellular mechanisms. Researchers worldwide rely on FMR1 monoclonal antibodies to explore neural development, synaptic plasticity, and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific understanding of neurological disorders and potential therapeutic interventions.